Core Viewpoint - The company announced a collaboration with Shanghai University of Traditional Chinese Medicine to establish the "Dong'e Ejiao Scholarship," with a total donation of 750,000 yuan over five years, aimed at promoting research and innovation in traditional Chinese medicine [2][2][2] Group 1: Donation and Collaboration - The company’s board approved a proposal for external donations, focusing on the establishment of a scholarship to support students [2][2] - The collaboration will concentrate on research in gelatin-based medicines, formulation standards, talent cultivation, and the innovation of traditional Chinese medicine culture [2][2] Group 2: Financial Impact - The donation is not expected to have a significant impact on the company's current or future financial status and will not affect normal production and operations [2][2] - For the first three quarters, the company reported total revenue of 4.766 billion yuan, a year-on-year increase of 4.41%, and a net profit attributable to shareholders of 1.274 billion yuan, up 10.53% year-on-year [2][2]